G
GNPX
Genprex Inc
3.650
+0.110+3.11%Opening10:42 09/23 EDT
OPEN/PREV CLOSE2.740/2.720
TODAY RANGE2.580-2.750
VOL165.26K
MARKET CAP2.14M
52 WEEK RANGE2.530-1,210.00
AVG VOL (3M)240.83K
% TURNOVER18.71%
TURNOVER--
P/E (TTM)-0.0151
% RANGE6.25%
EPS(TTM)-173.0075
P/E(FORWARD)-0.0009
P/B0.0893
BVPS29.23
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.13M
SHARES OUTSTANDING819.71K
NEXT EARNINGS11/12-11/16
FREE FLOAT817.95K
LOT SIZE1
EX-DATE07/16/2026
News
Press Releases
Financial Reports
Profile
Benzinga·09/28 21:06
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·08/18 11:29
Genprex advances AAV diabetes gene therapy manufacturing
TipRanks·08/18 11:10
Genprex selects manufacturing organization for diabetes gene therapy
Benzinga·08/17 21:06
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·08/05 21:30
Genprex Regains Nasdaq Compliance, Listing Status Secured
Benzinga·08/03 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·08/03 12:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·08/03 11:30
Genprex, Roche Partner on NSCLC Biomarker Validation
TipRanks·08/03 11:11
Genprex announces collaboration with Roche Diagnostics
TipRanks·07/30 21:27
Genprex Granted Nasdaq Listing Exception Amid Compliance Push
TipRanks·07/15 23:50
Genprex trading halted, news pending
TipRanks·07/15 07:58
Genprex Announces Reverse Stock Split Amid Nasdaq Compliance Push
TipRanks·06/22 13:57
Genprex Secures Canadian Patent for Reqorsa Lung Cancer Therapy
Same Industry
Name/Symbol
Change%
Price